Purpose: To evaluate and compare the feasibility and safety of robotlc or open SRP for localized radio recurrent prostate cancer. Materials and Methods: Total of 62 patients .who underwent SRP due to biopsy proven prostate cancer from January 2007 to June 2011 were included. Forty-three patients with median age 67(48-76) underwent open SRP between January 2007-0ctober 2010(group I) and 19 patients with median age 66(51-76) underwent robotic assisted SRP (group 11) between September 2009-June 2011. The median values of PSA for group I and group 11 were 6.65 and 6.3 ng/ml respectively. The pre salvage median prostate specific antigens (PSAT were 3.6ng/ml (range, 0.2-13.7) and 1.8ng/ml (0-0.95) for group I and group 11 respectively. The Gleason score at initial diagnosis was identical for both groups 7(6-9). Urinary diversion was done in 11 patients in group I and no diversion was performed in group Il. Pelvic lymph node dissection was done 41 patients (97.76%) in group I and in 17 patients (89.47%) in group Il. Pre, peri and postoperative parameters as well as oncological and functional outcomes were evaluated and compared for both groups. Biochemical recurrence (BCR) after surgery was defined ~s detectable measurement of PSA after surgery. Continence was defined as being pad free and potency as enough erection for penetration with or without medication. The median follow up periods were 14 months (range, 1-66) and 6 months (range, 1-20) for both groups respectively. Results: None of the robotic SRP patients needed open conversion. The median operative time and blood loss in group I were 291 minutes (range,123-852) and 900 cc (range,150-8000) respectively, however the median vales for the same parameters in group 11 were 295 minutes (range, 234-536) and 275 cc(range, 100-1200) respectively. Blood transfusion was done for 12 patients (27.9%) and 2 patients (10.52%) in group I and group 11 respectively. Hospitalization for both groups were 4 day (range, 1-16) and 3 day(range, 1-7) respectively. Surgical margins were positive in 12 patients (27.9%) in group I and in 2 patients (10.52%) in group 11. Seminal vesicle involvements were found in 18 patients (41.8%) iA group I and in 9 patients (47.36%) in group 11.